Sleep Arousal-Related Ventricular Repolarization Lability Is Associated With Cardiovascular Mortality in Older Community-Dwelling Men

Sobhan Salari Shahrbabaki, Dominik Linz*, Susan Redline, Katie Stone, Kristine Ensrud, Mathias Baumert

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: Sleep is fragmented by brief arousals, and excessive arousal burden has been linked to increased cardiovascular (CV) risk, but mechanisms are poorly understood.

RESEARCH QUESTION: Do arousals trigger cardiac ventricular repolarisation lability that may predispose people to long-term cardiovascular mortality?

STUDY DESIGN AND METHODS: We analyzed 407,541 arousals in the overnight polysomnograms of 2558 older men in the Osteoporotic Fractures in Men Sleep Study. QT and RR intervals were measured beat-to-beat starting 15 seconds before arousal onset until 15 seconds past onset. Ventricular repolarisation lability was quantified by the QT variability index (QTVi).

RESULTS: During 10.1±2.5 years of follow-up, 1000 men died from any cause, including 348 CV deaths. During arousals, QT and RR variability increased on average by 5 and 55 ms, respectively, resulting in a paradoxical transient decrease in QTVi from 0.07±1.68 to -1.00±1.68. Multivariable Cox proportional hazard analysis adjusted for age, BMI, cardiovascular and respiratory risk factors, sleep disordered breathing and arousal, diabetes and Parkinson's disease indicated that excessive QTVi during arousal was independently associated with all-cause and CV mortality (all-cause: HR=1.20 [1.04-1.38], p=0.012; CV: 1.29 [1.01 -1.65], p=0.043).

INTERPRETATION: Arousals affect ventricular repolarisation. A disproportionate increase in QT variability during arousal is associated with an increased all-cause and CV mortality and may reflect ventricular repolarisation maladaptation to the arousal stimulus. Whether arousal-related QTVi can be used for more tailored risk stratification warrants further study, including evaluating whether arousal suppression attenuates ventricular repolarisation lability and reduces subsequent mortality.

CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Identifier: NCT00070681.

Original languageEnglish
Pages (from-to)419-432
Number of pages14
JournalChest
Volume163
Issue number2
Early online date13 Oct 2022
DOIs
Publication statusPublished - Feb 2023

Fingerprint

Dive into the research topics of 'Sleep Arousal-Related Ventricular Repolarization Lability Is Associated With Cardiovascular Mortality in Older Community-Dwelling Men'. Together they form a unique fingerprint.

Cite this